Bladder cancer trials in China

In China 167 Also abroad 626

167 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 2Taking people
Neoadjuvant Adebrelimab Plus Etoposide and Cisplatin in Neuroendocrine Bladder Carcinoma
Where
Chengdu, Nanjing, Shanghai, Tianjin, Xi’an
Age
18 years to 75 years
People
22
Run by
RenJi Hospital
See details and how to joinNCT06091124
Phase 1/2Not yet taking people in China
Entinostat & Chemotherapy for Locally Advanced or Metastatic Bladder Cancer
Where
Nanjing
Age
18 years to 75 years
People
29
Run by
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
See details and how to joinNCT07261592
No phaseTaking people
Investigation Into the Integration of Intracavitary Cryoablation and Immunotherapy in Bladder-Preserving Therapy
Where
Shanghai
Age
18 years to 85 years
People
180
Run by
Changhai Hospital
See details and how to joinNCT07204132
Phase 2Taking people
A Study of SI-B003 and BL-B01D1+SI-B003 in Patients With Locally Advanced or Metastatic Urothelial Carcinoma and Other Solid Tumors
Where
Shanghai
Age
18 years to 75 years
People
52
Run by
Sichuan Baili Pharmaceutical Co., Ltd.
See details and how to joinNCT05965856
No phaseTaking people
Compression Stockings to Prevent Peripheral Neuropathy Caused by Antibody-Drug Conjugates in Urothelial Carcinoma Patients
Where
Shanghai
Age
18 years to 75 years
People
58
Run by
Sheng Zhang
See details and how to joinNCT07164950
Phase 2Not yet taking people in China
A Clinical Study Evaluating the Efficacy and Safety of Disitamab Vedotin Combined With PD-1 Inhibitor and Radiotherapy as Bladder-preserving Therapy in Patients With Localized HER2-high Expressing Muscle-invasive Bladder Urothelial Carcinoma Following Maximal Transurethral Resection
Where
Shanghai
Age
18 years and over
People
45
Run by
RenJi Hospital
See details and how to joinNCT07142200
Phase 2Taking people
Ivonescimab in the Treatment of Multiple Advanced Tumors
Where
Shanghai
Age
18 years and over
People
400
Run by
Fudan University
See details and how to joinNCT06683846
No phaseTaking people
Construction of a Deep Learning-Based Precise Diagnostic Framework for Bladder Tumors Using Ultrasound: A Multicenter, Ambispective Cohort Study
Where
Beijing
Age
18 years to 85 years
People
400
Run by
Peking University First Hospital
See details and how to joinNCT07111364
Phase 2Taking people
Neoadjuvant Tislelizumab in Combination With Nab-Paclitaxel for UTUC
Where
Tianjin
Age
18 years and over
People
35
Run by
Tianjin Medical University Second Hospital
See details and how to joinNCT07126119
Phase 1/2Taking people
A Study of Intravesical FL115 Alone or in Combination With BCG in Non-Muscle Invasive Bladder Cancer
Where
Beijing, Changsha, Chengdu, Fuzhou, Nanjing, Qingdao, Shanghai, Suzhou, Tianjin, Wenzhou
Age
18 years and over
People
80
Run by
Suzhou Forlong Biotechnology Co., Ltd
See details and how to joinNCT07122414
Phase 1/2Taking people
Clinical Trail of Neoadjuvant of Tislelizumab Combined With Palbociclib in Patients With Platinum-refractory Bladder Urothelial Carcinoma
Where
Changsha, Guangzhou, Wuhan
Age
18 years and over
People
36
Run by
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
See details and how to joinNCT06364956
No phaseTaking people
Prognostic Effect of Whether Doing PLND During RC for High-risk NMIBC
Where
Nanjing
Age
18 years to 75 years
People
200
Run by
The First Affiliated Hospital with Nanjing Medical University
See details and how to joinNCT05123625
Phase 4Taking people
Impact of Remimazolam on Prognosis After Bladder Cancer Surgery
Where
Beijin, Beijing, Guiyang, Nanjing, Shanghai
Age
50 years to 90 years
People
1,128
Run by
Peking University First Hospital
See details and how to joinNCT04532606
No phaseNot yet taking people in China
Antarctic Krill Oil Functional Food Mitigates Bladder Cancer Treatment Side Effects
Where
Jinan
Age
18 years to 75 years
People
210
Run by
Qilu Hospital of Shandong University
See details and how to joinNCT06880939
Phase 3Taking people
A Phase III Study of SHR-A2102 Versus Investigator-selected Therapy in Advanced Urothelial Carcinoma
Where
Beijing
Age
18 years to 80 years
People
402
Run by
Shanghai Hengrui Pharmaceutical Co., Ltd.
See details and how to joinNCT06738251
No phaseTaking people
Bladder Cancer Staging and Prediction of New Adjuvant Chemotherapy Efficacy Based on Deep Learning and Transfer Learning in Ultrasound-Magnetic Resonance-Pathology Multimodal Multiscale
Where
Guangzhou
People
480
Run by
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
See details and how to joinNCT07051083
No phaseTaking people
A Study Comparing the Necessity of a Second Transurethral Resection in High-Risk Non-Muscle-Invasive Bladder Cancer Patients With Negative Results From Post-Initial Resection Urine Genome-Wide Low-Depth Sequencing
Where
Nanjing
Age
18 years to 80 years
People
428
Run by
The First Affiliated Hospital with Nanjing Medical University
See details and how to joinNCT07036731
Early phase 1Enrolling by invitation
PET Image Exploration of 89Zr-labeled Antibody Fragments Targeting HER2 in Patients With Malignant Tumors
Where
Wuxi
Age
18 years to 75 years
People
10
Run by
Affiliated Hospital of Jiangnan University
See details and how to joinNCT07023848
Early phase 1Enrolling by invitation
The Exploration of Novel Radionuclide-labeled HER2-targeting Antibodies in the Diagnosis of HER2-positive Malignancies
Where
Wuxi
Age
15 years to 75 years
People
20
Run by
Affiliated Hospital of Jiangnan University
See details and how to joinNCT07023861
No phaseTaking people
Deep Learning Radiomics Model for Predicting Post-cystectomy Outcome in Muscle Invasive Bladder Cancer
Where
Chongqing
People
500
Run by
First Affiliated Hospital of Chongqing Medical University
See details and how to joinNCT06092450
No phaseNot yet taking people in China
Clinical Application of PET Imaging Targeting Nectin-4 in Malignant Tumors
Where
Wuhan
Age
18 years to 65 years
People
56
Run by
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
See details and how to joinNCT06994078
No phaseTaking people
A Multicenter Prospective Cohort Study on Monitoring Recurrence of Urothelial Carcinoma Based on Detection of Urinary Microscopic Residual Disease (MRD)
Where
Beijing
Age
18 months and over
People
300
Run by
Peking University First Hospital
See details and how to joinNCT06991868
Phase 1/2Not yet taking people in China
Disitamab Vedotin Combined With Ivonescimab in Cisplatin-Ineligible Muscle-Invasive Bladder Cancer
Where
Guangzhou
Age
18 years and over
People
30
Run by
Sun Yat-sen University
See details and how to joinNCT06957561
No phaseTaking people
Prospective Evaluation of Cornerstone Robotics Sentire Surgical System in Major Gastrointestinal and Urologic Surgery
Where
Hong Kong
Age
18 years to 80 years
People
90
Run by
Chinese University of Hong Kong
See details and how to joinNCT06926374
Phase 2Not yet taking people in China
Neoadjuvant Chemotherapy in High - Risk Upper Tract Urothelial Carcinoma
Where
Shanghai
Age
18 years and over
People
45
Run by
Changhai Hospital
See details and how to joinNCT06927128